Related Experiment Video

Updated: Apr 20, 2026

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth
09:10

Synthesis of Masarimycin, a Small Molecule Inhibitor of Gram-Positive Bacterial Growth

Published on: January 7, 2022

2.8K

A small molecule species specifically inhibits Fusarium myosin I

Chengqi Zhang1, Yun Chen1, Yanni Yin1

  • 1Institute of Biotechnology, Zhejiang University, Hangzhou, 310058, China.

Environmental Microbiology
|November 19, 2014
PubMed

Insights

A new fungicide, JS399-19, targets a specific protein in Fusarium graminearum, offering effective control for Fusarium head blight (FHB) in crops. This species-specific action highlights its environmental compatibility and potential for novel antifungal drug development.

Area of Science:

  • Agricultural Science
  • Mycology
  • Biochemistry

Background:

  • Fusarium head blight (FHB), caused by Fusarium graminearum, is a significant global threat to cereal crops.
  • A novel, environmentally compatible fungicide, JS399-19, demonstrates species-specific activity against certain Fusarium species.

Purpose of the Study:

  • To elucidate the mode of action of the species-specific fungicide JS399-19.
  • To identify the molecular target of JS399-19 in Fusarium graminearum.

Main Methods:

  • Whole-genome transcript profiling was employed to analyze the fungicide's effects.
  • Genetic assays, including gene transformation and point mutation analysis, were conducted.
  • Biochemical assays assessed the impact of JS399-19 on enzyme activity.

Main Results:

  • JS399-19 was identified to target myosin I of Fusarium graminearum (FgMyo1), a protein crucial for fungal growth.
  • Specific point mutations (S217L or E420K) in FgMyo1 confer resistance to JS399-19.
  • Transformation with myosin I from other fungi also induced resistance, confirming the target specificity.
  • JS399-19 inhibits the ATPase activity of wild-type FgMyo1 but not the mutated forms.

Conclusions:

  • The fungicide JS399-19 specifically targets FgMyo1, providing a new avenue for managing FHB.
  • Understanding this species-specific mechanism aids in designing targeted antifungal agents.
  • The employed strategy can be applied to discover novel drug targets in other pathogenic organisms.

More Related Videos

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays05:57

Author Spotlight: Exploring Cytoskeletal Dynamics to Unveil Novel Antibiotics Through Innovative Cell-Based Assays

Published on: April 26, 2024

1.4K
Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos12:35

Author Spotlight: Optogenetic Inhibition of Rho1-Mediated Actomyosin Contractility Coupled with Measurement of Epithelial Tension in Drosophila Embryos

Published on: April 14, 2023

2.0K

Related Concept Videos

Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
95.5K
Actin Filament Depolymerization01:19

Actin Filament Depolymerization

Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
4.3K
Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to...
106
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K
The Electron Transport Chain01:30

The Electron Transport Chain

The electron transport chain or oxidative phosphorylation is an exothermic process in which free energy released during electron transfer reactions is coupled to ATP synthesis. This process is a significant source of energy in aerobic cells, and therefore inhibitors of the electron transport chain can be detrimental to the cell's metabolic processes.
Inhibitors of the electron transport chain
Rotenone, a widely used pesticide, prevents electron transfer from Fe-S cluster to ubiquinone or Q...
21.9K
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
82